Resistance exercise for seniors does not require heavy weights or gym memberships
Hamal S, Cherukuri L, Shaikh K, Kinninger A, Doshi J, Birudaraju D et al (2020) Effect of semaglutide on coronary atherosclerosis progression in patients with type II diabetes: rationale and design of the semaglutide treatment on coronary progression trial
Standard titration protocol from clinical trials The Phase 2 NEJM trial used the following escalation schedule for the 12 mg dose group: Weeks 1 through 4: 2 mg once weekly (subcutaneous) Weeks 5 through 8: 4 mg once weekly Weeks 9 through 12: 8 mg once weekly Week 13 and beyond: 12 mg once weekly (maintenance dose) For the 8 mg target dose, the schedule was: Weeks 1 through 4: 2 mg once weekly Weeks 5 through 8: 4 mg once weekly Week 9 and beyond: 8 mg once weekly (maintenance dose) These titration schedules are not suggestions
Ahmed M, Arun A, Pfeferman M, Rashedi S, Zuin M, Secemsky E, Goldhaber S, Monreal M, Jimenez D, Piazza G, Krumholz H , Bikdeli B
Those with Pre-existing CKD: If your kidney function is already significantly reduced, your reserve for handling a bout of dehydration is lower
Non-Surgical Solutions Non-surgical options for loose skin after weight loss, especially after retatrutide